Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you are due to have surgery, you should stop Wegovy before your procedure. NHS England advises all patients taking GLP-1 medicines — including semaglutide — to tell their healthcare team and anaesthetist before any surgical procedure, because slowed gastric emptying can increase the risk of regurgitation and pulmonary aspiration under anaesthesia. How far in advance you stop is a clinical decision your surgical team and prescriber will make together, based on the type of operation, the anaesthetic planned and your individual circumstances. This page covers what is currently known, where genuine uncertainty remains, and who needs to be involved in that decision.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Semaglutide reduces the speed at which your stomach empties food into the small intestine. That effect is part of how it helps reduce appetite and calorie intake. Under general or deep sedation anaesthesia, a stomach that still contains food or liquid (even hours into a standard nil-by-mouth window) carries a real risk: if stomach contents reflux into the throat, they can be inhaled into the lungs. Pulmonary aspiration of this kind is a serious and potentially life-threatening anaesthetic complication.
NHS England's guidance on weight-management injections explicitly states that patients should tell their healthcare team, including the anaesthetist, that they are taking a GLP-1 medicine before any surgical procedure. The practical consequence is that your team may extend your fasting period, modify the anaesthetic approach, or ask you to stop the medicine for a set period beforehand.
The gastric-emptying effect does not disappear the moment you skip a dose. Semaglutide is a once-weekly injection with a half-life of approximately one week, meaning meaningful drug levels persist for several weeks after the last dose. A quick check you can do in under a minute: look at your pen and note the date of your last injection, then pass that information directly to your surgical team so they can calculate exactly where you are in your dosing cycle.
This is the question with the least settled answer, and honesty about that uncertainty matters here. At the time of writing, no single pan-UK guideline specifies an exact stoppage interval for semaglutide before surgery. Different anaesthetic and surgical bodies have issued varying recommendations, some suggest one week (one missed dose), others suggest longer, particularly before major elective procedures under general anaesthesia.
The Royal College of Anaesthetists and the Association of Anaesthetists have published evolving guidance on GLP-1 medicines and perioperative risk, and individual hospital trusts may have their own policies. Your surgeon's pre-assessment clinic is the right place to get the specific instruction that applies to your operation. They will factor in whether you are having a local, regional or general anaesthetic, whether the procedure is elective or urgent, and how well controlled your condition has been.
What is clear is that stopping without telling your prescriber creates a gap in your care record. Informing your prescriber at our support team or through your GP means your clinical history is accurate when you are ready to restart. You can read more about the broader picture of having surgery while on Wegovy on a dedicated page.
The timing of restarting is just as clinical as the timing of stopping. A straightforward day-case procedure under local anaesthetic carries very different considerations from major abdominal surgery that involves its own recovery period and potential changes to your appetite, fluid balance and gut function.
Restarting too soon after certain operations (particularly gastrointestinal surgery) may intensify nausea, delay healing or interfere with the nutritional intake your body needs for recovery. Restarting after bariatric procedures has its own distinct considerations; there is separate guidance on Wegovy after bariatric surgery for anyone in that position.
Your surgical team's discharge advice, read alongside input from whoever manages your weight-loss treatment, should determine when it is appropriate to pick up where you left off. If you are a patient at nume (sorry, at a clinician-led service like ours) your prescriber can review your situation before any repeat order is processed, which is standard practice for every clinical re-review at nume.
The short list: your surgical team (including the pre-assessment nurse), the anaesthetist, and the prescriber or pharmacy managing your Wegovy. If your GP is not already aware you are taking Wegovy (as is sometimes the case with private prescriptions) this is a good moment to notify them, and if you are also curious whether the medicine has had other effects on your habits, there is a dedicated page exploring whether Wegovy helps you stop drinking. NHS guidance supports GP notification as part of responsible prescribing, and having an accurate medicines list in your summary care record matters in any operative setting.
Tell them the name of the medicine (semaglutide / Wegovy), your current dose, and the date of your last injection. That is everything they need to factor it into your anaesthetic and perioperative plan. If you have questions about how nume handles prescriber-to-GP communication, the frequently asked questions page covers the notification process. For a broader overview of the surgery and semaglutide topic, the surgery and Wegovy guidance page sets out the fuller clinical picture. And if you are yet to start treatment and weighing up the broader considerations first, the Wegovy overview is a practical starting point, including details on how to get Wegovy delivered once you are ready to begin, or you can start your free consultation to speak with one of our prescribers directly.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.